163 related articles for article (PubMed ID: 9162244)
1. [Changes in clinico-immunological indices of experimental allergic encephalomyelitis after treatment with perftoran].
Zhitnukhin IuL; Litvinenko IV; Bisaga GN; Odinak MM
Biull Eksp Biol Med; 1997 Mar; 123(3):315-8. PubMed ID: 9162244
[No Abstract] [Full Text] [Related]
2. Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates.
Lisak RP; Zweiman B; Kies MW; Driscoll B
J Immunol; 1975 Feb; 114(2 Pt 1):546-9. PubMed ID: 47353
[TBL] [Abstract][Full Text] [Related]
3. The role of myelin lipids in experimental allergic encephalomyelitis.
Hosein ZZ; Gilbert JJ; Strejan GH
Prog Clin Biol Res; 1984; 146():49-54. PubMed ID: 6201918
[No Abstract] [Full Text] [Related]
4. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
[No Abstract] [Full Text] [Related]
5. Formed blood elements in peritoneal effusion and the macrophage migration inhibition test in healthy guinea pigs and in guinea pigs with experimental allergic encephalomyelitis.
Wróblewski T
Arch Immunol Ther Exp (Warsz); 1976; 24(3):359-66. PubMed ID: 60984
[TBL] [Abstract][Full Text] [Related]
6. Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea-pig.
Pekárek J; Vepreková A; Doutlík S
Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):139-46. PubMed ID: 4143076
[No Abstract] [Full Text] [Related]
7. Basic protein from central nervous system myelin.
Hashim GA
Prog Clin Biol Res; 1980; 49():79-122. PubMed ID: 6163164
[No Abstract] [Full Text] [Related]
8. [Some immunological manifestations of experimental allergic encephalomyelitis (author's transl)].
Rysková O; Nozicka Z; Vejbora O; Pekárek J
Cesk Epidemiol Mikrobiol Imunol; 1982 Jan; 31(1):21-9. PubMed ID: 6174247
[No Abstract] [Full Text] [Related]
9. Survey of recent studies on mechanism and significance of delayed (cellular)-type hypersensitivity.
Johanovský J; Pekárek J
Ann Immunol Hung; 1972; 16(0):191-8. PubMed ID: 4137958
[No Abstract] [Full Text] [Related]
10. Delayed hypersensitivity studies in experimental allergic encephalomyelitis; a comparison of macrophage migration inhibition tests and electrophoretic mobility.
Hughes D; Caspary EA; Field EJ
Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):14-9. PubMed ID: 4251430
[No Abstract] [Full Text] [Related]
11. [Macrophage migration inhibition test (M.I.T) in experimental allergic encephalitis].
Del rey Calero J; Calbo Torrecillas F; Otero Puime AA; Gonzalez R-Salinas MC
Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1307-18. PubMed ID: 5525220
[No Abstract] [Full Text] [Related]
12. The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
Tabira T; Itoyama Y; Kuroiwa Y
Prog Clin Biol Res; 1984; 146():43-8. PubMed ID: 6201912
[No Abstract] [Full Text] [Related]
13. In vitro stimuli required for enhanced transfer of experimental allergic encephalomyelitis with myelin basic protein sensitized guinea pig peritoneal exudate cells.
Fujii T; Driscoll BF
Prog Clin Biol Res; 1984; 146():299-305. PubMed ID: 6201902
[No Abstract] [Full Text] [Related]
14. [Problems in CNS...with special reference to immunology of experimental allergic encephalomyelitis (author's transl)].
Nagai K; Akiyama G
Rinsho Shinkeigaku; 1977 Dec; 17(12):849-53. PubMed ID: 75776
[No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid lymphocytes in experimental allergic encephalomyelitis.
Wilkerson LD; Lisak RP; Zweiman B
Clin Exp Immunol; 1978 Oct; 34(1):87-91. PubMed ID: 86401
[TBL] [Abstract][Full Text] [Related]
16. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
Seil FJ; Agrawal HC
Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
[No Abstract] [Full Text] [Related]
17. [Prevention of development of experimental allergic encephalomyelitis by encephalitogenic protein].
Zhitnukhin IuL; Sofronov BN; Beme DKh; Baĭkovskaia MN
Patol Fiziol Eksp Ter; 1978; (5):55-60. PubMed ID: 83596
[No Abstract] [Full Text] [Related]
18. [The immunological effects of perftoran].
Pluzhnikov NN; Lobzin IuV; Kovelenov AIu; Zhelezkova EV; Gusev DA
Eksp Klin Farmakol; 1998; 61(5):34-6. PubMed ID: 9854631
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of immunoadsorbent treatment in experimental allergic encephalomyelitis].
Hurina NM; Bardakhivs'ka KI; Kuchmerovs'ka TM
Fiziol Zh (1994); 2008; 54(6):79-86. PubMed ID: 19227244
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response in guinea pigs at different stages of experimental allergic encephalomyelitis.
Lassmann H; Karcher D; Kitz K; Lowenthal A; Noppe M; Verslegers W
Prog Clin Biol Res; 1984; 146():171-8. PubMed ID: 6201887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
